Interleukin 2

Interleukin-2 is a form of Interleukin. It is important in medicine because it is an effective treatment for metastatic renal cell carcinoma and Metastatic melanoma. It can produce up to a 16% response rate in patients with Metastatic melanoma.[1] and a slightly lower 15% response rate in metastatic renal cell carcinoma.[2]

References

  1. ↑ "Proleukin (Aldesleukin) - Metastatic Melanoma Clinical Data". Archived from the original on 2011-05-24. Retrieved 2010-05-04.
  2. ↑ "Renal Cell Carcinoma - PROLEUKIN". Archived from the original on 2009-06-04. Retrieved 2010-05-04.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.